sharecast

{{ storiesRelated.title }}

Broker Recommendations
31 Mar
hikma drugs generics
Wednesday broker round-up

Hikma: Jefferies upgrades to buy with a target price of 2,870p.

31 Mar
housing, construction, building
Berenberg raises target price on Vistry

Analysts at Berenberg raised their target on construction firm Vistry Group from 1,210. 0p to 1,270. 0p on Wednesday, stating there was still more gains to come despite the stock's recent rise.

31 Mar
hikma drugs generics
Jefferies upgrades Hikma to 'buy'

Analysts at Jefferies upgraded drugmaker Hikma Pharmaceuticals from 'hold' to 'buy' on Wednesday, stating the group's share price was yet to reflect "a series of upcoming product catalysts".